Sophie Viaud
Overview
Explore the profile of Sophie Viaud including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
22
Citations
2997
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Pennell C, Campbell H, Storlie M, Bolivar-Wagers S, Osborn M, Refaeli Y, et al.
J Immunother Cancer
. 2022 Dec;
10(12).
PMID: 36521930
Current Food and Drug Administration (FDA)-approved CD19-specific chimeric antigen receptor (CAR) T-cell therapies for B-cell malignancies are constitutively active and while efficacious, can cause morbidity and mortality. Their toxicities might...
2.
Mitchell L, Yagiz K, Hofacre A, Viaud S, Munday A, Espinoza F, et al.
Oncotarget
. 2019 May;
10(23):2252-2269.
PMID: 31040917
Immune checkpoint inhibitors (CPIs) are associated with a number of immune-related adverse events and low response rates. We provide preclinical evidence for use of a retroviral replicating vector (RRV) selective...
3.
Viaud S, Ma J, Hardy I, Hampton E, Benish B, Sherwood L, et al.
Proc Natl Acad Sci U S A
. 2018 Oct;
115(46):E10898-E10906.
PMID: 30373813
Chimeric antigen receptor (CAR) T cells with a long-lived memory phenotype are correlated with durable, complete remissions in patients with leukemia. However, not all CAR T cell products form robust...
4.
Besse B, Charrier M, Lapierre V, Dansin E, Lantz O, Planchard D, et al.
Oncoimmunology
. 2016 May;
5(4):e1071008.
PMID: 27141373
Dendritic cell-derived exosomes (Dex) are small extracellular vesicles secreted by viable dendritic cells. In the two phase-I trials that we conducted using the first generation of Dex (IFN-γ-free) in end-stage...
5.
Goldszmid R, Dzutsev A, Viaud S, Zitvogel L, Restifo N, Trinchieri G
Cancer Immunol Res
. 2015 Feb;
3(2):103-9.
PMID: 25660553
Myeloid cells represent a major component of the tumor microenvironment, where they play divergent dual roles. They can induce antitumor immune responses, but mostly they promote immune evasion, tumor progression,...
6.
Zitvogel L, Galluzzi L, Viaud S, Vetizou M, Daillere R, Merad M, et al.
Sci Transl Med
. 2015 Jan;
7(271):271ps1.
PMID: 25609166
Changes in the interactions among the gut microbiota, intestinal epithelium, and host immune system are associated with many diseases, including cancer. We discuss how environmental factors infuence this cross-talk during...
7.
Dzutsev A, Goldszmid R, Viaud S, Zitvogel L, Trinchieri G
Eur J Immunol
. 2014 Oct;
45(1):17-31.
PMID: 25328099
Commensal microorganisms colonize barrier surfaces of all multicellular organisms, including those of humans. For more than 500 million years, commensal microorganisms and their hosts have coevolved and adapted to each...
8.
Pitt J, Charrier M, Viaud S, Andre F, Besse B, Chaput N, et al.
J Immunol
. 2014 Jul;
193(3):1006-11.
PMID: 25049431
Exosomes are nanometric membrane vesicles of late endosomal origin released by most, if not all, cell types as a means of sophisticated intercellular communication. A multitude of studies showed how...
9.
Viaud S, Daillere R, Yamazaki T, Lepage P, Boneca I, Goldszmid R, et al.
Oncoimmunology
. 2014 May;
3(1):e27574.
PMID: 24800167
Cyclophosphamide, one of the most efficient tumoricidal, antiangiogenic, and immunostimulatory drugs employed to date mediates part of its effects through intestinal bacteria, against which the host becomes immunized during treatment....
10.
Viaud S, Saccheri F, Mignot G, Yamazaki T, Daillere R, Hannani D, et al.
Science
. 2013 Nov;
342(6161):971-6.
PMID: 24264990
Cyclophosphamide is one of several clinically important cancer drugs whose therapeutic efficacy is due in part to their ability to stimulate antitumor immune responses. Studying mouse models, we demonstrate that...